The new plan allows plaintiffs who sued Purdue to opt in to receive their settlement or reserve their right to file a civil suit against the billionaire Sackler family.

Purdue is expected to raise and contribute $900m while dissolving and transforming into a new public benefit company. The non-profit company that emerges will develop and distribute opioid use ...

Purdue Pharma Files New Bankruptcy Plan for $7.4 Billion Opioid Settlement By Dietrich Knauth NEW YORK (Reuters) -Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday ...

Purdue Pharma on Wednesday filed a new bankruptcy reorganization plan to resolve mass lawsuits alleging that the OxyContin maker and its Sackler family owners contributed to the opioid crisis.

Purdue Pharma has filed a new reorganization plan that aims to deliver more than $7.4 billion in cash to creditors, subject to certain reserves, to compensate victims and abate the opioid crisis.

Purdue Pharma Submits Opioid Lawsuit Settlement Plan, Including up to $7 Billion Cash From Sacklers Purdue Pharma asked a bankruptcy judge late Tuesday to consider the latest version of its plan ...

Purdue Pharma on Wednesday filed a new Chapter 11 ... a painkiller the company once marketed, helped fuel the country’s opioid epidemic. As part of the latest deal, the Sacklers are expected ...

STAMFORD, Conn., March 19, 2025--(BUSINESS WIRE)--Purdue Pharma L.P. ("Purdue") today filed a Chapter 11 Plan of Reorganization (the "Plan") and related disclosure statement with the United States ...

Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the company’s alleged role in the opioid crisis, months after the Supreme ...